Publications by authors named "Ismail Hdoufane"

Claim this Profile
D
Design, synthesis and molecular modeling of new Pyrazolyl-Benzimidazolone hybrids targeting breast Cancer.
Mohamed Adardour, Al-Hassan M Mustafa, Mehdi Oubahmane, Marouane Ait Lahcen, Emad M Seif, Ismail Hdoufane

Bioorg Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulations.
Ismail Hdoufane, Mehdi Oubahmane, Youssef Habibi, Christelle Delaite, Mohammed M Alanazi

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational design of potent dimeric phenylthiazole NS5A inhibitors for hepatitis C virus.
Wissal Liman, Mehdi Oubahmane, Nouhaila Ait Lahcen, Ismail Hdoufane, Driss Cherqaoui

Sci Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, characterization, X-ray, α-glucosidase inhibition and molecular docking study of new triazolic systems based on 1,5-benzodiazepine 1,3-dipolar cycloaddition reactions.
Marouane Ait Lahcen, Mohamed Adardour, Salma Mortada, Mehdi Oubahmane, Samir Hmaimou, Ismail Hdoufane

J Biomol Struct Dyn· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants.
Mohamed Adardour, Marouane Ait Lahcen, Mehdi Oubahmane, Walid Ettahiri, Ismail Hdoufane

Pharmaceuticals (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations.
Mehdi Oubahmane, Ismail Hdoufane, Christelle Delaite, Adlane Sayede, Driss Cherqaoui

Pharmaceuticals (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host Cell Proteases Mediating SARS-CoV-2 Entry: An Overview.
Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, Nouhaila Ait Lahcen, Didier Villemin

Curr Top Med Chem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid Molecules as Potential Drugs for the Treatment of HIV: Design and Applications.
Wissal Liman, Nouhaila Ait Lahcen, Mehdi Oubahmane, Ismail Hdoufane, Driss Cherqaoui

Pharmaceuticals (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monte Carlo Method and GA-MLR-Based QSAR Modeling of NS5A Inhibitors against the Hepatitis C Virus.
Wissal Liman, Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, Didier Villemin

Molecules· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico design and analysis of NS4B inhibitors against hepatitis C virus.
Ismail Hdoufane, Imane Bjij, Mehdi Oubahmane, Mahmoud E S Soliman, Didier Villemin

J Biomol Struct Dyn· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19: In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2.
Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, Carola Jerves, Didier Villemin

J Mol Struct· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrido[2',1':2,3]imidazo[4,5-]isoquinolin-5-amines as Potential Cytotoxic Agents against Human Neuroblastoma.
Zahira Tber, Mohammed Loubidi, Jabrane Jouha, Ismail Hdoufane, Mümin Alper Erdogan

Pharmaceuticals (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Silico SAR Studies of HIV-1 Inhibitors.
Ismail Hdoufane, Imane Bjij, Mahmoud Soliman, Alia Tadjer, Didier Villemin

Pharmaceuticals (Basel)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis